We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Wearable Robotic Gait Training Linked to Improved Walking Distance in ALS

By HospiMedica International staff writers
Posted on 15 Oct 2026

Amyotrophic lateral sclerosis (ALS) is a progressive neuromuscular disease that damages nerve cells controlling voluntary muscles. More...

As the disease advances, patients can lose the ability to walk, speak, swallow, and breathe independently. Rehabilitation is important because medications may slow progression but cannot reliably restore lost muscle strength. Researchers have now evaluated whether training with a wearable robotic system can improve walking performance while preserving short-term quality of life.

The study was conducted by researchers at Toho University in Japan and involved the Hybrid Assistive Limb (HAL; Cyberdyne, Inc.).  The wearable robotic device is designed to support gait training by responding to the user’s own intention to move. Skin sensors detect faint electrical signals generated by muscle activity, and the system uses those signals to assist walking exercises. HAL has been covered by Japan’s public health insurance for certain neuromuscular diseases, including ALS, since 2016.

The study included 30 patients with ALS who completed one course of HAL-assisted gait training. The intervention consisted of nine sessions over approximately four to five weeks. Each session lasted 20 to 40 minutes, including preparation and rest periods. Researchers assessed walking distance during a two-minute walking test and also measured walking speed, cadence, and step length over 10 meters.

After treatment, patients increased their average two-minute walking distance from about 92 meters to about 104 meters. This improvement of nearly 12 meters was statistically significant. However, walking speed, cadence, and step length during the 10-meter assessment did not change significantly. The findings suggest that patients covered more distance over two minutes, even though short-distance gait measures remained largely unchanged.

Quality of life was measured with the SF-36 questionnaire, which evaluates physical, mental, and social health domains. Before treatment, physical health and social role scores were lower than Japanese population averages, while mental well-being was relatively preserved. After one course of HAL training, none of the three main SF-36 component scores changed significantly. The study was published in Frontiers in Neurology under the title “Impact of Hybrid Assistive Limb on Gait Ability and Quality of Life in Patients with Amyotrophic Lateral Sclerosis.”

The researchers cautioned that the study did not include a control group, so the findings do not prove that HAL alone caused the walking improvement. They also noted that the clinical importance of an approximately 12-meter increase remains uncertain. Larger controlled studies with longer follow-up will be needed to determine whether HAL-assisted rehabilitation can sustain walking gains and affect daily activity or quality of life.

Related Links
Toho University
Cyberdyne, Inc.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Blood Gas Analyzer
i-Check200
Immobilization System
Cranial 4Pi Immobilization
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.